Well the numbers I have are:Cash est.of $2.1m (Sep-Q $0.6m plus $1.5m SPP).Estimated Dec-Q costs of $3.6m.Isn't that a deficit of $1.5m, less the lower than expected Dec-Q revenue?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025